Objectives: The Stent for Life (SFL) project's main mission is to increase the use of primary percutaneous coronary intervention (PCI) in more than 70% of all acute ST segment elevation myocardial infarction (STEMI) patients. Previous to the SFL project, thrombolysis was the dominant reperfusion strategy since a low percentage of acute STEMI patients had access to primary PCI in our country. In this study, we present the main barriers of access to primary PCI in the centers that were involved with the SFL project.

Study Design: Patients with acute STEMI admitted to the centers that were involved in the SFL project between 2009 and 2011 were included in the analysis.

Results: Since the inception of the SFL project, the primary PCI rate has reached over 90% in SFL pilot cities. In the last 5 years, the number of ambulances and emergency stations has increased. Since the collaboration with 112 Emergency Service, a great majority of cases were reached via the emergency medical system. The mean door-to-balloon time for the pilot cities was 54.72±43.66 minutes.

Conclusion: After three years of the SFL project, primary PCI has emerged as the preferred reperfusion strategy for patients with STEMI in pilot cities.

Download full-text PDF

Source
http://dx.doi.org/10.5505/tkda.2012.02488DOI Listing

Publication Analysis

Top Keywords

sfl project
16
primary pci
16
pilot cities
12
stemi patients
8
reperfusion strategy
8
acute stemi
8
access primary
8
centers involved
8
involved sfl
8
project primary
8

Similar Publications

Introduction: Patients with pulmonary embolism (PE) experience impaired functional ability and reduced quality of life long after discharge from the hospital. However, there are no structured follow-up programmes in Denmark for these patients, and there is considerable variation in practice patterns of post-PE management. No studies have investigated the effectiveness of structured follow-up care models in patients with PE.

View Article and Find Full Text PDF

In the rapidly evolving healthcare sector, using advanced technologies to improve medical classification systems has become crucial for enhancing patient care, diagnosis, and treatment planning. There are two main challenges faced in this domain (i) imbalanced distribution of medical data, leading to biased model performance and (ii) the need to preserve patient privacy and comply with data protection regulations. The primary goal of this project is to develop a medical classification model for Alzheimer's disease detection that can effectively learn from decentralized and imbalanced datasets without compromising on data privacy.

View Article and Find Full Text PDF

Background And Objective: Reports have suggested the use of intravenous infusion of vasopressors as an approach to prevent spinal anesthesia-induced hypotension (SAIH) in women undergoing cesarean deliveries. However, data on the suitability of this technique for obese people are limited. As such, the current experiment was designed to clarify the dose-response relationship associated with the preventive administration of phenylephrine to avoid SAIH during cesarean delivery in obese parturients under combined spinal-epidural anesthesia.

View Article and Find Full Text PDF

Background: Pyoderma gangrenosum (PG) is rare neutrophil skin disease causing painful, progressively enlarging ulcers. Among the treatment options, intravenous immunoglobulin (IVIG) is a therapy of first choice for paraneoplastic PG. Otherwise, it is used in therapy-refractory courses.

View Article and Find Full Text PDF

IL-9 sensitizes human T2 cells to proinflammatory IL-18 signals in atopic dermatitis.

J Allergy Clin Immunol

November 2024

Department of Dermatology, Inselspital, Bern University Hospital, Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland. Electronic address:

Background: T2 cells crucially contribute to the pathogenesis of atopic dermatitis (AD) by secreting high levels of IL-13 and IL-22. Yet the upstream regulators that activate T2 cells in AD skin remain unclear. IL-18 is a putative upstream regulator of T2 cells because it is implicated in AD pathogenesis and has the capacity to activate T cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!